Publication Date



Download Available for download on Tuesday, June 01, 2021

Download Full Text (466 KB)


Background: Neonatal herpes simplex virus (HSV) is a devastating disease with high mortality. In adults and children, genetic variants in the toll-like receptor 3 (TLR3) pathway increase susceptibility to herpes simplex encephalitis (HSE), but the genetic basis of susceptibility to neonatal HSV is unknown. We hypothesized that deleterious variants in the TLR3 pathway increased vulnerability to HSE in neonates. We investigated immunogenetic studies in an infant with neonatal skin, eye, mouth (SEM) HSV followed by HSE.

Objective: To combine exome sequencing with in vivo and in vitro immune functional analysis to discover the immunogenetic basis of HSV vulnerability in proband.

Design/Methods: The proband developed SEM HSV1 on day 7 of life and recovered fully with acyclovir. At 1 year of age he presented with seizures and was diagnosed with HSV1 HSE. Exome sequencing was performed to identify pathogenic genetic variants. An immune work up including peripheral blood monocyte (PBMC) functional TLR assay was done. Wild type and mutated alleles were transfected into THP1 monocyte cell line stably expressing an interferon regulatory factor 3 (IRF3) promoter-driven luciferase reporter. Poly(I:C) (1ug/mL), a TLR3 ligand, was used to stimulate THP1 for 24hr prior to luciferase assay and qRT-PCR for interferon (IFN) α and β gene expression.

Results: We identified rare missense mutations in interferon regulatory factor 7 (IRF7) (p.Arg100Pro) and UNC-93 Homolog B1 (UNC93B1) (p.Pro404Ser) genes. Immune work up including CD4, CD8, NK cell, and immunoglobulins was normal, except for a total loss of PBMC cytokine response to TLR3 stimulation (Fig.1). Luciferase assays in THP1 showed dramatically reduced TLR3-driven IRF3 promoter activity in response to poly(I:C) with IRF7 and UNC93B1 variants (Fig. 2 & 3). Similarly, IFNα and IFNβ expression induced by poly(I:C) was enhanced by wild type IRF7 and UNC93B1 alleles, but strongly suppressed by mutant IRF7 and UNC93B1 alleles (Fig. 2 & 3). Combining the 2 mutant alleles compounded disruption of TLR3 signaling (Fig. 4).

Conclusion(s): We identified 2 variants (IRF7, UNC93B1) that disrupted the TLR3-response to HSV in vitro and in vivo in an infant with recurrent HSV. This is the first report of human HSV disease associated with IRF7 mutation. Neonatal HSV may be a phenotype for immunodeficiency in the TLR3 pathway genes. Infants with severe neonatal HSV may warrant genetic screening to identify variants that increase recurrence risk, and prolonged acyclovir prophylaxis should be considered.

Presented at the 2021 PAS Virtual Conference


Allergy and Immunology | Pediatrics

Recurrent neonatal herpes simplex virus infection associated with IRF7 and UNC93B1 variants